欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2498/001
药品名称Striverdi Respimat
活性成分
    • olodaterol 2.5 µg
剂型Inhalation solution
上市许可持有人Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany
参考成员国 - 产品名称Netherlands (NL)
Striverdi Respimat 2,5 microgram, inhalatieoplossing
互认成员国 - 产品名称
    • Germany (DE)
      Striverdi Respimat 2,5 Mikrogramm/Hub Lösung zur Inhalation
    • Denmark (DK)
    • Belgium (BE)
      Striverdi Respimat
    • Luxembourg (LU)
    • Iceland (IS)
      Striverdi Respimat 2,5 míkróg Innöndunarlausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Liechtenstein (LI)
    • Austria (AT)
      Striverdi Respimat 2,5 Mikrogramm - Lösung zur Inhalation
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Striverdi
    • Finland (FI)
    • Poland (PL)
      Striverdi Respimat
    • Latvia (LV)
    • Lithuania (LT)
      Striverdi Respimat 2,5 mikrogramo/išpurškime inhaliacinis tirpalas
    • Estonia (EE)
      STRIVERDI RESPIMAT
    • Hungary (HU)
      STRIVERDI RESPIMAT 2,5 mikrogramm inhalációs oldat
    • Bulgaria (BG)
      Infortispir Respimat
    • Cyprus (CY)
      Infortispir Respimat Inhalation solution
    • Czechia (CZ)
      Striverdi Respimat 2,5 mikrogramů
    • Romania (RO)
      Infortispir Respimat 2,5 micrograme soluţie de inhalat
    • Slovakia (SK)
      Striverdi Respimat
    • Slovenia (SI)
    • Malta (MT)
      Striverdi Respimat 2.5mcg solution for inhalation
许可日期2013/09/04
最近更新日期2024/10/21
药物ATC编码
    • R03AC Selective beta-2-adrenoreceptor agonists
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase